Anika Therapeutics reported $29.43M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agenus AGEN:US $ 159.72M 3.34M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Anika Therapeutics ANIK:US $ 29.43M 2.44M
Arrowhead Research ARWR:US $ 128.21M 10.64M
Chemocentryx CCXI:US $ 76.08M 7.27M
Clovis Oncology CLVS:US $ 121.27M 0.56M
Enanta Pharmaceuticals ENTA:US $ 23.04M 7.7M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Immunogen IMGN:US $ 87.07M 2.95M
Insmed INSM:US $ 113.82M 11.43M
Integra Lifesciences IART:US $ 295.6M 20.24M
Intrexon XON:US $ 29.9M 4.3M
Karyopharm Therapeutics KPTI:US $ 62.54M 3.8M
Ligand Pharmaceuticals LGND:US $ 167.85M 125.28M
Macrogenics MGNX:US $ 50.88M 16.22M
Merit Medical Systems MMSI:US $ 195.59M 8.24M
Peregrine Pharmaceuticals PPHM:US $ 75.76M 1.54M
Rigel Pharmaceuticals RIGL:US $ 54.96M 4.27M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Stryker SYK:US $ 4404M 4M
Surmodics SRDX:US $ 29.39M 1.02M
Veracyte VCYT:US $ 59.34M 3.2M
Xencor XNCR:US $ 75.04M 14.1M
Zimmer Biomet Holdings Inc ZBH:US $ 2.46B 210.5M